DUBLIN, Calif., Nov 3 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008, at the New York Palace Hotel.
SuperGen's presentation at the Rodman & Renshaw 10th Annual Healthcare Conference is scheduled to begin at 11:35 a.m. EDT (8:35 a.m. PDT). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at http://www.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company
dedicated to the discovery and development of novel cancer therapies.
SuperGen is developing a number of therapeutic anticancer products focused
on kinase and cell signaling inhibitors and DNA methyltransferase
inhibitors. For more information about SuperGen, please visit
Timothy L. Enns
SVP, Corporate Communications
& Business Development
Tel: (925) 560-0100
Mary M. Vegh
Manager, Investor Relations
Tel: (925) 560-2845
Dorland Global Public Relations
Michael Beckerich (Media)
Tel: (212) 677-7632
|SOURCE SuperGen, Inc.|
Copyright©2008 PR Newswire.
All rights reserved